Portfolio (Quarterly)
Guide ↗
GF FUND MANAGEMENT CO. LTD.
· CIK 0002057060| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 521 | RGNX | REGENXBIO Inc | Healthcare | 1,075.0 | $13K | — | NEW | — | $11.98 | -38.2% |
| 522 | CSR | Centerspace | Real Estate | 229.0 | $13K | — | NEW | — | $56.19 | -1.6% |
| 523 | JBGS | JBG SMITH Properties | Real Estate | 803.0 | $12K | — | NEW | — | $14.67 | -28.2% |
| 524 | ALT | Altimmune Inc | Healthcare | 3,844.0 | $12K | — | NEW | — | $3.04 | +0.7% |
| 525 | ARVN | Arvinas Inc | Healthcare | 1,356.0 | $11K | — | NEW | — | $8.31 | -8.7% |
| 526 | PRTA | Prothena Corp PLC | Healthcare | 1,141.0 | $11K | — | NEW | — | $9.79 | -15.3% |
| 527 | CBL | CBL & Associates Properties In | Real Estate | 210.0 | $11K | — | NEW | — | $53.09 | -2.2% |
| 528 | WSR | Whitestone REIT | Real Estate | 587.0 | $11K | — | NEW | — | $18.96 | +0.2% |
| 529 | — | Berkshire Hathaway Inc | — | 22.0 | $11K | — | NEW | — | $500.41 | — |
| 530 | KYTX | Kyverna Therapeutics Inc | Healthcare | 1,212.0 | $11K | — | NEW | — | $8.91 | -23.6% |
| 531 | AQST | Aquestive Therapeutics Inc | Healthcare | 2,583.0 | $11K | — | NEW | — | $4.16 | +12.5% |
| 532 | PACB | Pacific Biosciences of Califor | Healthcare | 6,391.0 | $11K | — | NEW | — | $1.68 | -3.6% |
| 533 | SLN | Silence Therapeutics PLC | Healthcare | 975.0 | $11K | — | NEW | — | $10.98 | +1.8% |
| 534 | CTNM | Contineum Therapeutics Inc | Healthcare | 647.0 | $11K | — | NEW | — | $16.39 | -23.4% |
| 535 | NGNE | Neurogene Inc | Healthcare | 332.0 | $10K | — | NEW | — | $31.45 | -10.0% |
| 536 | ESRT | Empire State Realty Trust Inc | Real Estate | 1,906.0 | $10K | — | NEW | — | $5.41 | -24.0% |
| 537 | CABA | Cabaletta Bio Inc | Healthcare | 3,223.0 | $10K | — | NEW | — | $3.11 | -33.4% |
| 538 | — | Safehold Inc | — | 633.0 | $10K | — | NEW | — | $15.70 | — |
| 539 | EDIT | Editas Medicine Inc | Healthcare | 3,033.0 | $10K | — | NEW | — | $3.24 | -20.4% |
| 540 | GLPG | Lakefront Biotherapeutics NV | Healthcare | 317.0 | $10K | — | NEW | — | $29.98 | -6.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
70.8%
Consumer Cyclical
9.0%
Communication Services
6.0%
Healthcare
4.5%
Consumer Defensive
3.9%
Industrials
1.9%
Energy
1.8%
Utilities
0.8%
Financial Services
0.6%
Basic Materials
0.6%